Health Industry News

Pharmacy Guild of Australia & VIVA! Communications clinch Australia’s Best Public Health Initiative 2018 at PRIME Awards

Last night (September 20) Team VIVA! celebrated a huge win. Together with the Pharmacy Guild of Australia, we clinched Australia’s‘Best Public Health Initiative 2018’award for our ‘Enhancing ‘community immunity’ through pharmacist-led flu vaccinationcampaign at the pharmaceutical industry’s annual PRIME Awards. Held at The Four Seasons Hotel, Sydney, the event attracted more than 800 of the…

Read More

ACCC announces clearance of the merger of Arrow Pharmaceuticals & Apotex Australia & NZ merger

Melbourne, September 20, 2018 – The Australian Competition and Consumer Commission (ACCC) announced this morning that it ‘has decided not to oppose the merger of generic pharmaceutical companies, Arrow and Apotex’ after finding the transaction would not substantially lessen competition in any market. In May 2018, Strides Pharma Science Ltd and Apotex Inc. announced their…

Read More

GLOBALHealthPR appoints VIVA! Communications ‘Asia-Pacific hub’ & welcomes Spurwing Communications as exclusive Singaporean partner

GLOBALHealthPR, the world’s largest partnership of independent health and science communications agencies, today appointed longstanding Australian partner, VIVA! Communications, ‘regional hub’ for Asia-Pacific. The strategic partnership also welcomed Singapore-based Spurwing Communications to its network today, further strengthening GLOBALHealthPR’s capabilities in the Asia-Pacific (APAC) region. Having earned an enviable reputation for servicing the local, regional and…

Read More

Doctors sound alarm bell at lack of qualified nurses in aged care sector

Doctors have this week raised an alarm regarding the lack of qualified nurses working in the Australian aged care sector. According to the AMA’s most recent Aged Care survey, 35% of doctor respondents plan to stop accepting new patients, to reduce or completely cease their aged-care visits within the next two years. The survey involved…

Read More

Pharmaxis granted FDA clearance to produce Aridol locally for US market

ASX-listed pharmaceutical company, Pharmaxis has today been granted FDA clearance to commence Sydney-based production of its asthma diagnostic medication, Aridol for the US. The approval follows hot-on-the-heels of the FDA’s recent inspection of the Sydney facility which manufactures Aridol for Australia, South Korea and Europe, and Bronchitol for Australia, Europe and Russia respectively. Following FDA…

Read More